The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Toxoid Vaccines Market Research Report 2024
Synopsis
For bacteria that secrete toxins, or harmful chemicals, a toxoid vaccine might be the answer. These vaccines are used when a bacterial toxin is the main cause of illness. Scientists have found that they can inactivate toxins by treating them with formalin, a solution of formaldehyde and sterilized water. Such “detoxified” toxins, called toxoids, are safe for use in vaccines.
When the immune system receives a vaccine containing a harmless toxoid, it learns how to fight off the natural toxin. The immune system produces antibodies that lock onto and block the toxin. Vaccines against diphtheria and tetanus are examples of toxoid vaccines.
The global Toxoid Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Toxoid Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Toxoid Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Toxoid Vaccines include GlaxoSmithKline, Merck, Pfizer, Sanofi Pasteur, AstraZeneca, Bharat Biotech, Shenzhen Kangtai Biological Products, Bausch Health and Emergent Biosolutions, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Toxoid Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Toxoid Vaccines.
Report Scope
The Toxoid Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Toxoid Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Toxoid Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Merck
Pfizer
Sanofi Pasteur
AstraZeneca
Bharat Biotech
Shenzhen Kangtai Biological Products
Bausch Health
Emergent Biosolutions
Astellas Pharma
Panacea Biotec
Segment by Type
Monovalent Tetanus Toxoid (TT)
Diphtheria
Tetanus
Pertussis (DTaP)
Diphtheria and Tetanus (DT)
Segment by Application
Hospitals and Clinics
Government Organizations
Research
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Toxoid Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Toxoid Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
For bacteria that secrete toxins, or harmful chemicals, a toxoid vaccine might be the answer. These vaccines are used when a bacterial toxin is the main cause of illness. Scientists have found that they can inactivate toxins by treating them with formalin, a solution of formaldehyde and sterilized water. Such “detoxified” toxins, called toxoids, are safe for use in vaccines.
When the immune system receives a vaccine containing a harmless toxoid, it learns how to fight off the natural toxin. The immune system produces antibodies that lock onto and block the toxin. Vaccines against diphtheria and tetanus are examples of toxoid vaccines.
The global Toxoid Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Toxoid Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Toxoid Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Toxoid Vaccines include GlaxoSmithKline, Merck, Pfizer, Sanofi Pasteur, AstraZeneca, Bharat Biotech, Shenzhen Kangtai Biological Products, Bausch Health and Emergent Biosolutions, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Toxoid Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Toxoid Vaccines.
Report Scope
The Toxoid Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Toxoid Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Toxoid Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Merck
Pfizer
Sanofi Pasteur
AstraZeneca
Bharat Biotech
Shenzhen Kangtai Biological Products
Bausch Health
Emergent Biosolutions
Astellas Pharma
Panacea Biotec
Segment by Type
Monovalent Tetanus Toxoid (TT)
Diphtheria
Tetanus
Pertussis (DTaP)
Diphtheria and Tetanus (DT)
Segment by Application
Hospitals and Clinics
Government Organizations
Research
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Toxoid Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Toxoid Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Toxoid Vaccines Market Overview
1.1 Product Overview and Scope of Toxoid Vaccines
1.2 Toxoid Vaccines Segment by Type
1.2.1 Global Toxoid Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Monovalent Tetanus Toxoid (TT)
1.2.3 Diphtheria
1.2.4 Tetanus
1.2.5 Pertussis (DTaP)
1.2.6 Diphtheria and Tetanus (DT)
1.3 Toxoid Vaccines Segment by Application
1.3.1 Global Toxoid Vaccines Market Value by Application: (2024-2030)
1.3.2 Hospitals and Clinics
1.3.3 Government Organizations
1.3.4 Research
1.3.5 Others
1.4 Global Toxoid Vaccines Market Size Estimates and Forecasts
1.4.1 Global Toxoid Vaccines Revenue 2019-2030
1.4.2 Global Toxoid Vaccines Sales 2019-2030
1.4.3 Global Toxoid Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Toxoid Vaccines Market Competition by Manufacturers
2.1 Global Toxoid Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Toxoid Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Toxoid Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Toxoid Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Toxoid Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Toxoid Vaccines, Product Type & Application
2.7 Toxoid Vaccines Market Competitive Situation and Trends
2.7.1 Toxoid Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Toxoid Vaccines Players Market Share by Revenue
2.7.3 Global Toxoid Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Toxoid Vaccines Retrospective Market Scenario by Region
3.1 Global Toxoid Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Toxoid Vaccines Global Toxoid Vaccines Sales by Region: 2019-2030
3.2.1 Global Toxoid Vaccines Sales by Region: 2019-2024
3.2.2 Global Toxoid Vaccines Sales by Region: 2025-2030
3.3 Global Toxoid Vaccines Global Toxoid Vaccines Revenue by Region: 2019-2030
3.3.1 Global Toxoid Vaccines Revenue by Region: 2019-2024
3.3.2 Global Toxoid Vaccines Revenue by Region: 2025-2030
3.4 North America Toxoid Vaccines Market Facts & Figures by Country
3.4.1 North America Toxoid Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Toxoid Vaccines Sales by Country (2019-2030)
3.4.3 North America Toxoid Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Toxoid Vaccines Market Facts & Figures by Country
3.5.1 Europe Toxoid Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Toxoid Vaccines Sales by Country (2019-2030)
3.5.3 Europe Toxoid Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Toxoid Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Toxoid Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Toxoid Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Toxoid Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Toxoid Vaccines Market Facts & Figures by Country
3.7.1 Latin America Toxoid Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Toxoid Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Toxoid Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Toxoid Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Toxoid Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Toxoid Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Toxoid Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Toxoid Vaccines Sales by Type (2019-2030)
4.1.1 Global Toxoid Vaccines Sales by Type (2019-2024)
4.1.2 Global Toxoid Vaccines Sales by Type (2025-2030)
4.1.3 Global Toxoid Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Toxoid Vaccines Revenue by Type (2019-2030)
4.2.1 Global Toxoid Vaccines Revenue by Type (2019-2024)
4.2.2 Global Toxoid Vaccines Revenue by Type (2025-2030)
4.2.3 Global Toxoid Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Toxoid Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Toxoid Vaccines Sales by Application (2019-2030)
5.1.1 Global Toxoid Vaccines Sales by Application (2019-2024)
5.1.2 Global Toxoid Vaccines Sales by Application (2025-2030)
5.1.3 Global Toxoid Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Toxoid Vaccines Revenue by Application (2019-2030)
5.2.1 Global Toxoid Vaccines Revenue by Application (2019-2024)
5.2.2 Global Toxoid Vaccines Revenue by Application (2025-2030)
5.2.3 Global Toxoid Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Toxoid Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Toxoid Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline Toxoid Vaccines Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Toxoid Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Toxoid Vaccines Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Toxoid Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Toxoid Vaccines Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Sanofi Pasteur
6.4.1 Sanofi Pasteur Corporation Information
6.4.2 Sanofi Pasteur Description and Business Overview
6.4.3 Sanofi Pasteur Toxoid Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Pasteur Toxoid Vaccines Product Portfolio
6.4.5 Sanofi Pasteur Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Toxoid Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AstraZeneca Toxoid Vaccines Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Bharat Biotech
6.6.1 Bharat Biotech Corporation Information
6.6.2 Bharat Biotech Description and Business Overview
6.6.3 Bharat Biotech Toxoid Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bharat Biotech Toxoid Vaccines Product Portfolio
6.6.5 Bharat Biotech Recent Developments/Updates
6.7 Shenzhen Kangtai Biological Products
6.6.1 Shenzhen Kangtai Biological Products Corporation Information
6.6.2 Shenzhen Kangtai Biological Products Description and Business Overview
6.6.3 Shenzhen Kangtai Biological Products Toxoid Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shenzhen Kangtai Biological Products Toxoid Vaccines Product Portfolio
6.7.5 Shenzhen Kangtai Biological Products Recent Developments/Updates
6.8 Bausch Health
6.8.1 Bausch Health Corporation Information
6.8.2 Bausch Health Description and Business Overview
6.8.3 Bausch Health Toxoid Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bausch Health Toxoid Vaccines Product Portfolio
6.8.5 Bausch Health Recent Developments/Updates
6.9 Emergent Biosolutions
6.9.1 Emergent Biosolutions Corporation Information
6.9.2 Emergent Biosolutions Description and Business Overview
6.9.3 Emergent Biosolutions Toxoid Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Emergent Biosolutions Toxoid Vaccines Product Portfolio
6.9.5 Emergent Biosolutions Recent Developments/Updates
6.10 Astellas Pharma
6.10.1 Astellas Pharma Corporation Information
6.10.2 Astellas Pharma Description and Business Overview
6.10.3 Astellas Pharma Toxoid Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Astellas Pharma Toxoid Vaccines Product Portfolio
6.10.5 Astellas Pharma Recent Developments/Updates
6.11 Panacea Biotec
6.11.1 Panacea Biotec Corporation Information
6.11.2 Panacea Biotec Toxoid Vaccines Description and Business Overview
6.11.3 Panacea Biotec Toxoid Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Panacea Biotec Toxoid Vaccines Product Portfolio
6.11.5 Panacea Biotec Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Toxoid Vaccines Industry Chain Analysis
7.2 Toxoid Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Toxoid Vaccines Production Mode & Process
7.4 Toxoid Vaccines Sales and Marketing
7.4.1 Toxoid Vaccines Sales Channels
7.4.2 Toxoid Vaccines Distributors
7.5 Toxoid Vaccines Customers
8 Toxoid Vaccines Market Dynamics
8.1 Toxoid Vaccines Industry Trends
8.2 Toxoid Vaccines Market Drivers
8.3 Toxoid Vaccines Market Challenges
8.4 Toxoid Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
